Lori S Friedman

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Positive Breast Cancer

Top Venues

Science (New York, N.Y.)

Cancer research communications

Journal of medicinal chemistry

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Madeline A Dorso, Payal T Patel, Aleksandr Pankov, Jacob A Boyer, Rajesh Kumar Soni, Isabella S Del Priore, Omar Hayatt, Amanda Kulick, Connor J Hagen, Elisa De Stanchina, Melissa R Junttila, Anneleen Daemen, Lori S Friedman, Ronald C Hendrickson, Sarat Chandarlapaty
A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer. Cancer research communications 3 (9) (2023)
Emily J Hanan, Marie-Gabrielle Braun, Robert A Heald, Calum MacLeod, Connie Chan, Saundra Clausen, Kyle A Edgar, Charles Eigenbrot, Richard Elliott, Nicholas Endres, Lori S Friedman, Emily Gogol, Xiao-Hui Gu, Rebecca Hong Thibodeau, Philip S Jackson, James R Kiefer, Jamie D Knight, Michelle Nannini, Raman Narukulla, Amanda Pace, Jodie Pang, Hans E Purkey, Laurent Salphati, Deepak Sampath, Stephen Schmidt, Steve Sideris, Kyung Song, Swathi Sujatha-Bhaskar, Mark Ultsch, Heidi Wallweber, Jianfeng Xin, SiewKuen Yeap, Amy Young, Yu Zhong, Steven T Staben
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα. Journal of medicinal chemistry (2022)
Kyung W Song, Kyle A Edgar, Emily J Hanan, Marc Hafner, Jason Oeh, Mark Merchant, Deepak Sampath, Michelle A Nannini, Rebecca Hong, Lilian Phu, William F Forrest, Eric Stawiski, Stephen Schmidt, Nicholas Endres, Jane Guan, Jeffrey J Wallin, Jonathan Cheong, Emile G Plise, Gail D Lewis Phillips, Laurent Salphati, Timothy P Heffron, Alan G Olivero, Shiva Malek, Steven T Staben, Donald S Kirkpatrick, Anwesha Dey, Lori S Friedman
RTK-dependent inducible degradation of mutant PI3Kα drives GDC-0077 (Inavolisib) efficacy. Cancer discovery (2021)
Neil Vasan, Pedram Razavi, Jared L Johnson, Hong Shao, Hardik Shah, Alesia Antoine, Erik Ladewig, Alexander N Gorelick, Ting-Yu Lin, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew T Chang, Barry S Taylor, Maura N Dickler, Komal Jhaveri, Sarat Chandarlapaty, Raúl Rabadán, Ed Reznik, Melissa Laird Smith, Robert Sebra, Frauke Schimmoller, Timothy R Wilson, Lori S Friedman, Lewis C Cantley, Maurizio Scaltriti, Jose Baselga
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors. Science (New York, N.Y.) 366 (6466) (2020)